Stay updated with breaking news from Ralph Torbay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update KIMMTRAK net revenues of $67.6 million in Q4 2023 and $238.7 million in 2023; increasing...
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update KIMMTRAK (tebentafusp) net revenues of $67.6...
Full Year and Q4 2023 Earnings Summary: KIMMTRAK Drives Revenue Surge as Clinical Pipeline Progresses
Immunocore Holdings plc (NASDAQ:IMCR) Q2 2023 Earnings Call Transcript August 10, 2023 Immunocore Holdings plc beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.4. Operator: Greetings. Welcome to the Immunocore Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. A question and answer […]